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ABSTRACT
Background. White adipose tissue (WAT) is essential for energy storage as well
as being an active endocrine organ. The secretion of adipokines by adipocytes can
affect whole body metabolism, appetite, and contribute to overall health. WAT is
comprised of lipid-laden mature adipocytes, as well as immune cells, endothelial cells,
pre-adipocytes, and adipose-derived stem cells. In addition, the presence of extracellular
matrix (ECM)proteins inWATcan actively influence adipocyte differentiation, growth,
and function. Type I collagen is an abundant fibrous ECM protein in WAT that is
secreted by developing adipocytes. However, the extent and overall effect of Type I
collagen on adipokine secretion in mature adipocytes when added exogenously has not
been established.
Methods. We characterized the effects of Type I collagen overlays prepared using two
different buffers on adipocyte physiology and function when added at different times
during differentiation. In addition, we compared the effect of collagen overlays when
adipocytes were cultured on two different tissue culture plastics that have different
adherent capabilities. Triglyceride accumulation was analyzed to measure adipocyte
physiology, and leptin and adiponectin secretion was determined to analyze effects on
adipokine secretion.
Results. We found that collagen overlays, particularly when added during the early
differentiation stage, impaired adipokine secretion from mature adipocytes. Collagen
prepared using PBS had a greater suppression of leptin than adiponectin while collagen
prepared using HANKS buffer suppressed the secretion of both adipokines. The use of
CellBind plates further suppressed leptin secretion. Triglyceride accumulation was not
substantially impacted with any of the collagen overlays.
Discussion. Adipokine secretion can be selectively altered by collagen overlays. Thus,
it is feasible to selectively manipulate the secretion of adipokines by adipocytes in vitro
by altering the composition or timing of collagen overlays. The use of this technique
could be applied to studies of adipokine function and secretion in vitro as well as having
potential therapeutic implications to specifically alter adipocyte functionality in vivo.
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Keywords Adipognenesis, Type I collagen, Adiponectin, Leptin, Cell culture, Triglycerides,
3T3-L1
How to cite this article Christian et al. (2018), Collagen overlays can inhibit leptin and adiponectin secretion but not lipid accumulation
in adipocytes. PeerJ 6:e4641; DOI 10.7717/peerj.4641
INTRODUCTION
White adipocytes serve a crucial function in storing free fatty acids in the form of
triglycerides (TG) for energy use (Berry et al., 2013) and to prevent toxic deposition of
free fatty acids in ectopic sites (Bays, Mandarino & Defronzo, 2004). Mature, lipid-laden
adipocytes develop from fate-committed pre-adipocytes through the activation of a
series of well-regulated transcription factors culminating in the increased expression of
CCAAT/enhancer-binding protein alpha (C/EBP-α) and peroxisome proliferator-activator
receptor gamma (PPAR-γ ), often termed the ‘‘master regulators’’ of adipogenesis. Increased
expression of C/EBP-α and PPAR-γ promote the expression of key proteins essential for
lipid and carbohydrate storage proteins, such as glucose transporter 4 (Glut4) and perilipin
(Plin1), allowing the formation of large lipid droplets that store TG and cholesteryl esters,
which are a primary phenotype of terminally differentiated mature adipocytes (Berry et
al., 2013).
In addition to its energy storing role, white adipose tissue (WAT) can modulate
numerous tissues via secretion of adipokines. Key adipokines include adiponectin, which
is inversely associated with obesity and increased with fasting, and leptin, which is elevated
in obese individuals and decreased with fasting (Stern, Rutkowski & Scherer, 2016). Both
adiponectin and leptin are secreted from terminally differentiated adipocytes, and they act
on WAT as well as distal tissues. For example, adiponectin enhances insulin sensitivity and
induces the expansion of WAT, which prevents the toxic deposition of free fatty acids in
other organs (Yamauchi et al., 2001; Yamauchi et al., 2002; Berg et al., 2001; Xu et al., 2003),
whereas leptin acts through the sympathetic nervous system to induce lypolysis of WAT
(Zeng et al., 2015). In contrast, both adiponectin and leptin can promote glucose uptake
by skeletal muscle (Tomas et al., 2002; Bates et al., 2002). Moreover, leptin promotes the
proliferation of breast cancer cells (Ray, Nkhata & Cleary, 2007; Soma et al., 2008; Dubois
et al., 2014) while adiponectin inhibits their proliferation (Li et al., 2011). Thus, adipokines
secreted by WAT have multiple and varied effects on selected tissues and cells.
The role of the extracellular environment on adipocyte function remains incompletely
understood (Huang & Greenspan, 2012; Poulos et al., 2015). Adipocytes are supported by
extracellular matrix (ECM) proteins, where laminin, fibronectin, and collagen types I–VI
are the major constituents, with the precise ECM composition differing between species
andWAT depots (Mariman &Wang, 2010). Adipocytes express and secrete ECM proteins,
and collagen synthesis during early adipogenesis may promote adipocyte differentiation.
Different densities of ECM proteins can cause adipocytes that are grown on ECM scaffolds
to alter the in vitro secretion of adipokines such as adiponectin and Monocyte Chemoat-
tractant Protein-1 (MCP-1) (Li et al., 2010). In addition, pre-adipocytes can actively
remodel the ECM via the secretion of matrix metalloproteinases (Christiaens et al., 2008).
Systems to model the ECM-adipocyte interactions using collagen-embedded pre-
adipocytes or adipocytes for biological study or as ameans to engineer tissue for engraftment
have been described; however, they are often complicated, require specialized equipment, or
do notmodel the in vivoECM(Von Heimburg et al., 2003; Stacey et al., 2009;Chun & Inoue,
2014). Here, one of our aims was to establish a technique that is simpler than embedding
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adipocytes within a three-dimensionalmatrix, wouldmaintain the pre-adipocyte/adipocyte
interaction with the ECM, and would still allow for co-culture analysis with other cell types
in future studies. We used this technique to examine the effect of Type I collagen, a
highly abundant protein in adipocyte ECM (Mariman &Wang, 2010) that is commercially
available, and was previously used with success for adipocyte cultures (Von Heimburg et al.,
2003; Stacey et al., 2009; Chun & Inoue, 2014). We found a differential effect of the collagen
preparation on TG accumulation, and leptin or adiponectin secretion that was further
affected by timing and the type of tissue culture (TC) plastic used. These findings suggest
that minor manipulations to the ECM surrounding adipocytes can selectively affect their
physiology or function.
MATERIALS AND METHODS
Cells and Adipogenesis assay
3T3-L1 cells were obtained from the American Type Culture Collection (Manassas, VA,
USA) and confirmed to be free of mycoplasma contamination using the MycoAlert assay
(Lonza, Basel, Switzerland). All media and supplements were obtained from Invitrogen
Life Technologies (Waltham, MA, USA) unless otherwise indicated. Cells were maintained
in high-glucose (25 mM) DMEM supplemented with 10% newborn calf serum, 1%
penicillin/streptomycin, and 1% sodium pyruvate (DMEM/NCS). Cells were cultured
in TC treated 24-well plates (Falcon cat. no. 353226) or CellBind treated 24-well plates
(Corning cat. no. 3337). As shown in Fig. 1 and as previously described (Smith et al., 2015),
pre-adipocytes were plated at 5 ×104 cells per well to ensure 100% confluency after 24 h
and allowed to undergo cell-contact dependent growth arrest for further 24 h. At this time,
mediawere replacedwith growthmedia (high-glucoseDMEMsupplementedwith 10% fetal
bovine serum (FBS), 1% penicillin/streptomycin and 1% sodium pyruvate (DMEM/FBS))
containing 0.5 mM 3-isobutyl-1-methylxanthine (IBMX) and 1 µM dexamethasone (Dex)
(Millipore, Billerica, MA, USA), and cultured for 48 h. Then the medium was replaced
with DMEM/FBS containing 10 µg/ml insulin (Sigma-Aldrich, St. Louis, MO, USA) and
cultured for an additional 48 h. Media were then changed to DMEM/FBS and cells cultured
for up to five additional days with media replacement every 48 h with DMEM/FBS.
Collagen matrices
FibriCol R© collagen (cat. no. 5133-A)was obtained fromAdvancedBioMatrix Inc (Carlsbad,
CA, USA). The collagen was diluted to 3.3 mg/mL in PBS (1.9 mM NaH2PO4, 8.4 mM
Na2HPO4, 137 mM NaCl, pH 7.2) or in 1× HANKS buffer (1.26 mM CaCl2, 0.81 mM
MgSO4, 5.4 mM KCl, 0.44 mM KH2PO4, 137 mM NaCl, 0.34 mM Na2HPO4, 5.5 mM
D-glucose, 0.05 mM Phenol Red sodium salt, obtained as 10× concentrate cat. no.
0919101-54, MP Biomedicals, Santa Ana, CA, USA). Collagen in PBS (PBS-collagen) was
neutralized to pH 7–7.5 by addition of HCl prior to layering onto cells. Collagen in HANKS
was neutralized to pH 7–7.5 by addition of 250 mM HEPES (pH 7.2) (HANKS-collagen).
Collagen solutions or control solutions lacking collagen (300µL) were gently layered on top
of the adipocytes and allowed to polymerize at 37 ◦C for 40 min, thus generating a collagen
layer of an approximate thickness of 1.5 mm. For adipocytes not treated with collagen or
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Figure 1 Schematic diagram of 3T3-L1 adipogenesis and timing of collagen overlays. Pre-adipocytes
were cultured for 24 h on regular tissue-culture (TC) treated or CellBind plates, until they underwent
contact-dependent growth arrest. Collagen, or buffer only control, was overlaid at days 2, 4, or 6
and allowed to solidify for 40 min at 37 ◦C. Medium was overlaid onto the collagen or buffer after
the 40 min polymerization period. DMEM/FBS medium containing IBMX and dexamethasone
(DMEM/FBS+IBMX/Dex) was added at day 2, DMEM/FBS with insulin (DMEM/FBS+Insulin) was
added at day 4, and DMEM/FBS was added at day 6 and replaced every 48 h. Pre-adipocytes, prior to
induction of differentiation, are indicated by starburst shapes. Lipid droplets in mature adipocytes are
shown with small red circles. Addition of PBS-collagen or HANKS-collagen is indicated at day 2, 4, or 6.
Adiponectin and leptin concentrations were determined at day 9 and day 12, and TG accumulation was
determined at day 12.
Full-size DOI: 10.7717/peerj.4641/fig-1
buffer controls at that particular stage, medium was not removed. At the end of the 40 min,
after the collagen solutions were polymerized, 1 mL of medium, appropriate for the stage
of differentiation, was layered on top of the collagen layer or buffer solution (Fig. 1). At
day 2, the medium overlaid was DMEM/FBS with IBMX/Dex (DMEM/FBS+IBMX/Dex).
At day 4, the medium overlaid was DMEM/FBS with insulin (DMEM/FBS +Insulin). At
day 6, the medium overlaid was DMEM/FBS and replaced with DMEM/FBS every 48 h.
Triglyceride quantification
Media were removed at day 12 (Fig. 1); cells and collagen was washed twice with PBS and
then removed by scraping followed by re-suspension in 1 mL PBS. Lipids from the re-
suspended cells were extracted using the Bligh–Dyermethod (Bligh & Dyer, 1959), followed
by additional manipulations as follows. Following the removal of the organic solvent layer
from the Bligh-Dyer extraction, lipids remaining in the upper phase were re-extracted (in
duplicate) by adding 2.5 mL of chloroform, vortexing for 30 s, and centrifuging at 1,000×g
for 5 min. The organic solvent layer was removed and pooled with the organic solvent
layer from the Bligh-Dyer extraction. The pooled extracts were back extracted by mixing
with an equal volume of PBS, vortexing for 30 s, and centrifuging at 1,000 g for 5 min. The
organic solvent layer was removed, dried under N2(g), re-suspended in 500 µL isopropanol,
and stored under N2(g) at −20 ◦C until needed. To control for extraction efficiency, 10 µg
of a TG standard (cat. no. 17810; Sigma Aldrich, St. Louis, MO, USA) was extracted as
above, and the TG quantified with 25 µL of extracted sample (n= 11) was compared to
the TG quantified from 25 µL of 0.02 µg/µL TG standard (in isopropanol). TG cellular
accumulation was corrected for extraction efficiencies within each extraction procedure
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(mean extraction efficiency was 88.2% with a range of 79.8%–97.7%). A colorimetric
commercial kit from Wako Diagnostics (Richmond, VA, USA) was used to quantify TG,
using a standard curve of 0–50 µg TG.
Adiponectin and leptin quantification
Mouse leptin and adiponectin concentrations in the culture supernatant were determined
using DuoSet ELISA kits specific for mouse from R&D Systems (Minneapolis, MN,
USA) following the manufacturer’s instructions. Samples were analyzed in duplicate.
A 4-parameter log–logistic model was used to fit the data to the standard curves run
simultaneously using R v3.0 (R Core Team, 2015). Calibration curves were run to ensure
accurate dilution of the supernatants and found to require dilution of 1,024-fold for
adiponectin and no dilution for leptin. Samples where all replicates from one treatment
group had an absorbance below background are indicated as not detected (ND). For
samples with levels of leptin or adiponectin below the level of detection, the amount was
set to 8 pg/mL for leptin and 0.035 ng/mL for adiponection, which was just below the lowest
detectable concentration of 8.9 pg/mL and 0.039 ng/mL, respectively. Analysis of differences
were performed using Wilcoxon rank-sum analysis as samples with undetectable levels can
be included without compromising the analysis.
Statistical analysis
Statistical analysis was performed in R v3.0 (R Core Team, 2015), as indicated in the
respective figure legends. Experiments were repeated at least three times beginning with a
unique passage of 3T3-L1 cells. Each independent experiment was considered a biological
replicate. Differences were considered significant at P < 0.05.
RESULTS
Collagen matrices influence adipocyte function
We found that there was a statistically significant decrease in overall TG accumulation
with collagen overlays when assessed at day 12 (Fig. 2A). However, when we analyzed the
effects of the overlay at each timepoint, we found that there was no significant effect of
PBS-collagen on the total TG accumulation at any specific stage. In contrast, addition of
HANKS-collagen on day 2, but not day 4 or 6, resulted in a statistically significant reduction
in total TG (Fig. 2A).
We then analyzed leptin secretion at days 9 (Fig. 2B) and 12 (Fig. 2C), and we compared
the amount of leptin detected in the supernatant when collagen overlays were added at day
2, 4, or 6. Overall, we found that the addition of either PBS-collagen or HANKS-collagen
had an overall effect of suppressing leptin accumulation when analyzed at both days
9 and 12. The suppression was greater when the collagen was added at day 2 or day 4
compared to when added at day 6, with no leptin detected after collagen addition in most
cases (Figs. 2B–2C). Addition of collagen at day 6 did not significantly affect the amount
of leptin detected at day 9 but suppressed the amount of leptin detected at day 12 with
HANKS-collagen only. At day 9, the overall effect of PBS-collagen was statistically different
from HANKS-collagen, with statistically similar effects at day 12.
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Figure 2 Triglyceride (TG), leptin, and adiponectin production are differentially affected by PBS-
collagen and HANKS-collagen when cells are plated on regular TC-treated plates. (continued on next
page. . . )
Full-size DOI: 10.7717/peerj.4641/fig-2
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Figure 2 (. . .continued)
(A) Total TG in 3T3-L1 cells at day 12 after adding collagen overlays at days 2, 4 or 6. (B–E) Levels of se-
creted leptin and adiponectin were determined at day 9 (B, D) and day 12 (C, E). Note that leptin and
adiponectin concentrations are shown in Log10 scale as the changes in concentration can span multiple
orders of magnitude. Statistical analysis was done by 3-way ANOVA. A priori analysis of control vs. col-
lagen at each stage by T -test for TG and adiponectin and by Wilcoxon rank sum for leptin levels as some
samples were below the detection limit of the ELISA (ND, not detected). *P < 0.05, **P < 0.01, ***P <
0.001, shown are mean± sem of 3 independent biological replicates.
Adiponectin secretion was affected more by HANKS-collagen at both day 9 (Fig. 2D)
and 12 (Fig. 2E) when compared to PBS-collagen. Addition of HANKS-collagen, but not
PBS-collagen at day 2, resulted in a large and significant inhibition of adiponectin secretion
at day 9 (Fig. 2D). By day 12, adiponectin levels remained significantly lower in adipocytes
with HANKS-collagen added at day 2 or 4, but not at day 6, suggesting the effect is time-
or maturation-dependent (Fig. 2E). Addition of PBS-collagen significantly, but modestly,
suppressed adiponectin secretion by day 12 and at day 9 when added at day 4 only.
Effect of CellBind plates on adipocyte physiology and function in the
presence of collagen
The previous experiments were performed using typical TC treated plastic. However,
culturing 3T3-L1 cells on specially treated dishes with higher levels of incorporated
oxygen on the plastic, branded CellBind (Pardo et al., 2010), can increase the ease of the
adipogenesis assay because the cells remain more firmly attached. This effect is noticed
particularly after IBMX and Dex treatment at day 2 when the cells have a more rounded
morphology (SL Christian & NK Pallegar, 2015, unpublished data). Therefore, we sought
to determine if the addition of collagen overlays in combination with CellBind plates
would affect adipogenesis.
We first determined if CellBind plates affected adipocyte physiology or function in
the absence of collagen. As expected, we found a significant increase in the amount of
cellular TG, as well as a significant increase of secreted leptin and adiponectin, when cells
were induced to undergo adipogenesis compared to control (Neg) cells (Figs. 3A–3C).
We observed a trend towards an increase in TG accumulation when adipogenesis was
induced in the CellBind plates compared to regular TC plates (P = 0.07). Overall, there
was no significant effect of plate type on leptin or adiponectin secretion. However, we
observed spontaneous release of adiponectin on CellBind plates from control cells (Neg)
resulting in no significant increase in adiponectin secretion detected at day 9 in response
to adipogenesis induction (Pos) (Fig. 3C).
We next determined the effect of the collagen overlays on TG accumulation and
adipokine secretion when CellBind plates were used. Similar to the regular TC plates,
we found an overall suppression of TG accumulation in the presence of the collagen
overlays (Fig. 4A). However, the only significantly different pairwise comparison was
with PBS-collagen added at day 4. There was no overall significant difference between
PBS-collagen and HANKS-collagen on TG accumulation.
In contrast, we found that leptin levels on day 9 were particularly disrupted when
cells were treated with either buffer alone or collagen in either type of buffer during
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Figure 3 Adipogenesis is not significantly different when 3T3-L1 cells are cultured in regular tissue-
culture (TC) treated dishes or CellBind dishes. (A) Triglyceride accumulation at day 12, (B) leptin and
(C) adiponectin secretion at days 9 and 12 in cells culture on regular TC or CellBind plates in the absence
(Neg) or presence (Pos) of adipogenic inducers as described in the methods, with no buffer incubation
steps. Note that leptin and adiponectin concentrations are shown in Log10 scale as the changes in concen-
tration can span multiple orders of magnitude. Statistical analysis by 2-way ANOVA. A priori analysis of
control vs. collagen at each stage by T -test for TG and adiponectin and by Wilcoxon rank sum for leptin
levels as some samples were below the detection limit of the ELISA. *P < 0.05, **P < 0.01, ***P < 0.001.
Mean± sem shown of 3–4 independent biological replicates.
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adipogenesis (Fig. 4B), suggesting that leptin secretion from cells grown on CellBind plates
is more sensitive to any environmental disruption during adipogenesis, which occurs in
both conditions. However, by day 12 the amount of leptin detected from the cells without
collagen was similar to cells grown without disruption (compare Fig. 4C to Fig. 3B).
Addition of HANKS-collagen at day 4, but not day 2 or 6, resulted in a significant decrease
in leptin accumulation at day 12 (Fig. 4C). In addition, there was a significant overall
difference between the addition of PBS-collagen compared to HANKS-collagen in leptin
accumulation at day 12, with HANKS-collagen having a greater impact.
There was an overall significant decrease in adiponectin accumulation at days 9 and 12
with the addition of collagen (Figs. 4D–4E). Overlaying HANKS-collagen at day 4 resulted
in a significant decrease in adiponectin detected at both day 9 and day 12. Overlaying
PBS-collagen at day 4 caused a significant decrease when detected at day 12 but not day 9.
Moreover, the magnitude of the decrease in adiponectin accumulation was much less than
with TC plates (compare Figs. 4D–4E to Figs. 2D–2E).
DISCUSSION
Our goal was to determine if collagen matrix overlays would impact adipocyte physiology,
as measured by TG accumulation, and function, as measured by adipokine secretion. We
found that both physiology and function could be differentially affected by the addition
of collagen overlays in a manner that depended on when during adipogenesis the collagen
was added. Moreover, collagen overlays prepared using different buffers had differential
effects on adiponectin and leptin secretion.
Overall TG accumulation was generally suppressed by the addition of both PBS-collagen
and HANKS-collagen (Figs. 2A and 4A). However, only two timepoints showed a specific
reduction in TG accumulation when compared to without buffer alone, with neither
of the changes particularly substantial. Therefore, we conclude that the collagen matrix
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Figure 4 Triglyceride (TG), leptin, and adiponectin production are differentially affected by PBS-
collagen and HANKS-collagen when cells are plated on CellBind plate. (continued on next page. . . )
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Figure 4 (. . .continued)
(A) Total TG in 3T3-L1 cells at day 12 after adding collagen overlays at days 2, 4 or 6. (B–E) Levels of se-
creted leptin and adiponectin were determined at day 9 (B, D) and day 12 (C, E). Note that leptin and
adiponectin concentrations are shown in Log10 scale as the changes in concentration can span multiple
orders of magnitude. Statistical analysis by 3-way ANOVA. A priori analysis of control vs. collagen at each
stage by T -test for TG and adiponectin and by Wilcoxon rank sum for leptin levels as some samples were
below the detection limit of the ELISA (ND, not detected). *P < 0.05, **P < 0.01, ***P < 0.001. Mean±
sem of 3 independent biological replicates is shown.
overlays do not substantially alter the normal accumulation of lipid in mature adipocytes.
It remains to be determined if the modest decreases in TG accumulation would translate
to biologically relevant outcomes in an in vivo situation.
Our analysis of adipocyte function as determined by adipokine secretion revealed that
leptin and adiponectin can be affected by both the method of collagen matrix preparation
and the type of TC plastic used. We do not believe that the reduction in adipokine
detection is due to collagen physically blocking the passage of secreted proteins that were
subsequently detected by ELISA. Leptin has a calculated mass of approximately 19 kDa
protein while adiponectin has a calculated mass of 26 kDa. Since leptin was impacted
more than adiponectin, it is unlikely that the collagen matrices are reducing the passage
of secreted proteins based on size. Adiponectin is glycosylated in at least 6 sites (Richards
et al., 2006; Richards et al., 2010), whereas post-translational modifications of leptin, with
the exception of disulfide bonds, have not been reported. The predicted pI of leptin is
5.85, while the predicted pI of unmodified adiponectin is 5.57, suggesting that different
charges on the unmodified proteins of −2.5 and −6.4, respectively, could potentiate
charge-charge interactions between the adipokine and collagen. In fact, an interaction
between adiponectin and collagen has been reported previously in vitro and in injured
but not healthy blood vessels in vivo (Okamoto et al., 2000). However, leptin has not been
reported to interact with collagen. Moreover, equivalent amounts of leptin and adiponectin
were secreted when the collagen was added to more mature cells (i.e., at day 6). Thus, there
is no evidence to suggest that the collagen matrices physically impede the release of
adipokines into the surrounding media.
The adipocytes were exposed to an absence or reduction of glucose during the 40 min
collagen polymerization period for PBS and HANKS-based buffers, respectively. Reduced
adipogenesis is observed when cells are exposed to low glucose levels during early phases
of differentiation, corresponding to days 2–5 in our study, but not at later stages (Jackson
et al., 2017). The levels of TG, adiponectin, and leptin secreted by cells exposed to no/low
glucose buffer were similar to the controls by day 12 but generally lower at day 9 (compare
Fig. 2 to Figs. 3 and 4). Therefore, it appears that the cells are able to overcome any effects
of the short-term low glucose exposure given enough time for full differentiation and
maturation. However, differentiation of cells in the CellBind plate when combined with
the 40 min buffer or collagen incubation further reduced leptin secretion, particularly at
day 9, suggesting that firm binding of the cells to the plates affects their ability to withstand
other stressors, such as reduced glucose levels. Therefore, it is possible that the combination
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of reduced glucose in the presence of monomeric or polymerized collagen is necessary for
the full reduction in adipocyte function.
It is possible that, even after addition of media with sufficient glucose levels, the collagen
layers could impact nutrient or oxygen availability to the cells due to physical interference
of advective mixing. Unfortunately, it was not possible to control for this as the buffer
solutions, used as controls for the absence of media during polymerization, do not form
discrete layers. In fact, the buffer dilutes the media by ∼30% thus potentially decreasing
the nutrient availability as well as the adipokine concentration compared to the wells with
polymerized collagen. Therefore, we may be underestimating the reduction in adipokine or
TG secretion. Future studieswill be required to determine the concentration of key nutrients
and oxygen in the collagen layer or at the collagen-adipocyte interface in comparison to
the buffer controls to determine if this could be causing the effects we observed.
The collagen overlays could also decrease the clonal expansion that occurs during
adipogenesis of 3T3-L1 cells (Gregoire, Smas & Sul, 1998; Tang, Otto & Lane, 2003). This
re-entry into the cell cycle after contact-dependent growth arrest occurs during the early
phases of adipogenesis and could therefore be impacted by addition of collagen at day 2 or
4. If this were the case, we could expect a significant reduction in TG accumulation as, in
theory, there would be a reduction of up to 50% of the cells. Since we have not observed a
significant or substantial reduction in TG accumulation for most of the pairwise analysis,
we do not believe that this is the major mechanism. However, precise analysis of DNA
replication will be required to conclusively establish if the collagen overlays affect clonal
expansion.
Leptin was strongly affected by the addition of both types of collagenmatrices. Strikingly,
addition of collagen at the earlier stage of adipogenesis (day 2 or day 4) resulted in leptin
secretion that was, in many cases, below the level of detection. Thus, addition of collagen
during active differentiation decreases leptin secretion in a manner that is not readily
restored by additional time in culture. Leptin expression is regulated by a variety of
transcription factors including C/EBPα, SREBP1, and FosL1 during adipogenesis (Miller
et al., 1996; Mason et al., 1998; Wrann & Rosen, 2012). In addition, leptin expression is
promoted by insulin, glucocorticoids, and even leptin itself (Wrann & Rosen, 2012). The
ability of collagen or buffer to impair leptin secretion when added at early stages of
adipogenesis but not late stages suggests that these manipulations may be interfering with
the action of a regulator that acts early during adipogenesis. Elucidating the mechanism
for this stage-dependent effect will be an important focus for future study.
In contrast to leptin, effects of collagen overlays on adiponectin secretion were modest.
PBS-collagen had very little impact on adiponectin secretion while HANKS-collagen,
especially when associated with TC-treated plates measured at day 9, substantially
decreased the secretion of adiponectin. Adiponectin expression is regulated by insulin
via activation of PPAR- γ as well as by other transcription factors such as C/EBPα and
negatively regulated by FoxO1 (Shehzad et al., 2012). Thus, it appears that addition of
HANKS-collagen significantly impairs the regulation of adiponectin synthesis and/or
secretion, but this effect is reduced when cells are cultured in CellBind plates. While it is
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clear that collagen overlays differentially regulate the appearance of adiponectin and leptin,
the precise mechanism for this regulation will require further study.
It is not clear why the HANKS-collagen had different effects than PBS-collagen on
adipokine secretion when compared to their respective buffer controls. While we observed
that the HANKS-collagen solidified at a slower rate than PBS-collagen, both were solidified
completely within 24 h. The HANKS buffer contains potassium ions, CaCl2, MgSO4, and
D-glucose, which are absent in the PBS-collagen preparation. The differences in buffer
compositions did not cause obvious changes to the collagen overlays at themacroscale (data
not shown). We have not found any published studies on the specific interactions between
these molecules and collagen that may explain the differing cellular responses. Therefore,
future study will be necessary to dissect out the key factors that cause the functional changes
to the collagen matrices.
Regardless of the mechanism, we have clearly shown that manipulations to the
preparation of Type I collagen can result in significant and specific alterations to adipocyte
physiology and function. Thus, selective alteration of adipokine secretionwithout impacting
TG storage may be possible using collagen matrices. Adapting this method to in vivo
procedures could potentially be used to modify appetite-regulating hormones without
diminishing the essential role of adipocytes to store free fatty acids, which are toxic in high
abundance or when deposited ectopically (Bays, Mandarino & Defronzo, 2004).
CONCLUSIONS
In summary, we found that the secretion of leptin and adiponectin can be selectively
manipulated while not substantially impairing TG synthesis in developing adipocytes by
use of different collagen preparations and cell culture plates. These findings may provide
researchers a new way to affect adjacent cells or tissue by selectively manipulating adipocyte
function in vitro or, potentially in vivo.
ACKNOWLEDGEMENTS
We thank Zhe Dong and Erika Merschrod for helpful discussion and for providing the
collagen.
ADDITIONAL INFORMATION AND DECLARATIONS
Funding
This work was funded by Canadian Institutes of Health Research operating grants no.
126614 and 126754, withmatching funds from the Research andDevelopment Corporation
of Newfoundland grant 5404.1090.103, to Sherri L. Christian, and by a Natural Sciences
and Engineering Research Council of Canada Discovery grant (402185-2011-RGPIN) to
Robert J. Brown. Nikitha K. Pallegar is supported by a trainee award from the Beatrice
Hunter Cancer Research Institute with funds provided by the Terry Fox Strategic Health
Research Training Program in Cancer Research at CIHR and by Memorial University of
Christian et al. (2018), PeerJ, DOI 10.7717/peerj.4641 12/16
Newfoundland. The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Grant Disclosures
The following grant information was disclosed by the authors:
Canadian Institutes of Health Research: 126614, 126754.
Research and Development Corporation of Newfoundland: 5404.1090.103.
Natural Sciences and Engineering Research Council of Canada Discovery: 402185-2011-
RGPIN.
Beatrice Hunter Cancer Research Institute.
The Terry Fox Strategic Health Research Training Program in Cancer Research.
Competing Interests
The authors declare there are no competing interests.
Author Contributions
• Sherri L. Christian conceived and designed the experiments, performed the experiments,
analyzed the data, contributed reagents/materials/analysis tools, prepared figures and/or
tables, authored or reviewed drafts of the paper, approved the final draft.
• Nikitha K. Pallegar performed the experiments, analyzed the data, authored or reviewed
drafts of the paper, approved the final draft.
• Robert J. Brown conceived and designed the experiments, performed the experiments,
analyzed the data, authored or reviewed drafts of the paper, approved the final draft.
• Alicia M. Viloria-Petit conceived and designed the experiments, contributed
reagents/materials/analysis tools, authored or reviewed drafts of the paper, approved the
final draft.
Data Availability
The following information was supplied regarding data availability:
The raw data are provided in Data S1.
Supplemental Information
Supplemental information for this article can be found online at http://dx.doi.org/10.7717/
peerj.4641#supplemental-information.
REFERENCES
Bates SH, Gardiner JV, Jones RB, Bloom SR, Bailey CJ. 2002. Acute stimulation
of glucose uptake by leptin in l6 muscle cells. Hormone and Metabolic Research
34:111–115 DOI 10.1055/s-2002-23192.
Bays H, Mandarino L, Defronzo RA. 2004. Role of the adipocyte, free fatty acids, and
ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-
activated receptor agonists provide a rational therapeutic approach. Journal of
Clinical Endocrinology and Metabolism 89:463–478 DOI 10.1210/jc.2003-030723.
Christian et al. (2018), PeerJ, DOI 10.7717/peerj.4641 13/16
Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. 2001. The adipocyte-secreted
protein Acrp30 enhances hepatic insulin action. Nature Medicine 7:947–953
DOI 10.1038/90992.
Berry DC, Stenesen D, Zeve D, Graff JM. 2013. The developmental origins of adipose
tissue. Development 140:3939–3949 DOI 10.1242/dev.080549.
Bligh EG, DyerWJ. 1959. A rapid method of total lipid extraction and purification.
Canadian Journal of Biochemistry and Physiology 37:911–917 DOI 10.1139/y59-099.
Christiaens V, Scroyen I, Lijnen HR. 2008. Role of proteolysis in development of murine
adipose tissue. Thrombosis and Haemostasis 99:290–294.
Chun T-H, InoueM. 2014. 3-D adipocyte differentiation and peri-adipocyte collagen
turnover.Methods in Enzymology 538:15–34
DOI 10.1016/B978-0-12-800280-3.00002-5.
Dubois V, Jarde T, Delort L, Billard H, Bernard-Gallon D, Berger E, Geloen A, Vasson
MP, Caldefie-Chezet F. 2014. Leptin induces a proliferative response in breast
cancer cells but not in normal breast cells. Nutrition and Cancer 66:645–655
DOI 10.1080/01635581.2014.894104.
Gregoire FM, Smas CM, Sul HS. 1998. Understanding adipocyte differentiation.
Physiological Reviews 78:783–809 DOI 10.1152/physrev.1998.78.3.783.
Huang G, Greenspan DS. 2012. ECM roles in the function of metabolic tissues. Trends in
Endocrinology and Metabolism 23:16–22 DOI 10.1016/j.tem.2011.09.006.
Jackson RM, Griesel BA, Gurley JM, Szweda LI, Olson AL. 2017. Glucose avail-
ability controls adipogenesis in mouse 3T3-L1 adipocytes via up-regulation of
nicotinamide metabolism. Journal of Biological Chemistry 292:18556–18564
DOI 10.1074/jbc.M117.791970.
Li G, Cong L, Gasser J, Zhao J, Chen K, Li F. 2011.Mechanisms underlying the
anti-proliferative actions of adiponectin in human breast cancer cells, MCF7-
dependency on the cAMP/protein kinase-A pathway. Nutrition and Cancer 63:80–88
DOI 10.1080/01635581.2010.516472.
Li Q, Hata A, Kosugi C, Kataoka N, Funaki M. 2010. The density of extracellular matrix
proteins regulates inflammation and insulin signaling in adipocytes. FEBS Letters
584:4145–4150 DOI 10.1016/j.febslet.2010.08.033.
Mariman ECM,Wang P. 2010. Adipocyte extracellular matrix composition, dy-
namics and role in obesity. Cellular and Molecular Life Science 67:1277–1292
DOI 10.1007/s00018-010-0263-4.
MasonMM, He Y, Chen H, QuonMJ, ReitmanM. 1998. Regulation of leptin promoter
function by Sp1, C/EBP, and a novel factor 1. Endocrinology 139:1013–1022
DOI 10.1210/endo.139.3.5792.
Miller SG, De Vos P, Guerre-Millo M,Wong K, Hermann T, Staels B, Briggs MR,
Auwerx J. 1996. The adipocyte specific transcription factor C/EBPalpha modulates
human ob gene expression. Proceedings of the National Academy of Sciences of the
United States of America 93:5507–5511 DOI 10.1073/pnas.93.11.5507.
Okamoto Y, Arita Y, NishidaM,Muraguchi M, Ouchi N, Takahashi M, Igura T, Inui Y,
Kihara S, Nakamura T. 2000. An adipocyte-derived plasma protein, adiponectin,
Christian et al. (2018), PeerJ, DOI 10.7717/peerj.4641 14/16
adheres to injured vascular walls. Hormone and Metabolic Research 32:47–50
DOI 10.1055/s-2007-978586.
Pardo AMP, BryhanM, KrasnowH, Hardin N, Riddle M, LaChance O, Gagnon
PTU, Hoover DS. 2010. Corning R© CellBIND R© Surface: an improved surface for
enhanced cell attachment. Technical report XP002530385.
Poulos SP, DodsonMV, Culver MF, Hausman GJ. 2015. The increasingly com-
plex regulation of adipocyte differentiation. Experimental Biology and Medicine
241(5):449–456 DOI 10.1177/1535370215619041.
Ray A, Nkhata KJ, Cleary MP. 2007. Effects of leptin on human breast cancer cell lines in
relationship to estrogen receptor and HER2 status. International Journal of Oncology
30:1499–1509.
R Core Team. 2015. R: a language and environment for statistical computing. Vienna: R
Foundation for Statistical Computing. Available at https://www.R-project.org .
Richards AA, Colgrave ML, Zhang J, Webster J, Simpson F, Preston E,Wilks D, Hoehn
KL, StephensonM,Macdonald GA, Prins JB, Cooney GJ, Xu A,Whitehead JP.
2010. Sialic acid modification of adiponectin is not required for multimerization
or secretion but determines half-life in circulation.Molecular Endocrinology
24:229–239 DOI 10.1210/me.2009-0133.
Richards AA, Stephens T, Charlton HK, Jones A, Macdonald GA, Prins JB,Whitehead
JP. 2006. Adiponectin multimerization is dependent on conserved lysines in the
collagenous domain: evidence for regulation of multimerization by alterations
in posttranslational modifications.Molecular Endocrinology 20:1673–1687
DOI 10.1210/me.2005-0390.
Shehzad A, IqbalW, Shehzad O, Lee YS. 2012. Adiponectin: regulation of its production
and its role in human diseases. Hormones 11:8–20.
Smith NC, Fairbridge NA, Pallegar NK, Christian SL. 2015. Dynamic upregula-
tion of CD24 in pre-adipocytes promotes adipogenesis. Adipocyte 4:89–100
DOI 10.4161/21623945.2014.985015.
Soma D, Kitayama J, Yamashita H, Miyato H, IshikawaM, Nagawa H. 2008. Leptin
augments proliferation of breast cancer cells via transactivation of HER2. Journal of
Surgical Research 149:9–14 DOI 10.1016/j.jss.2007.10.012.
Stacey DH, Hanson SE, Lahvis G, Gutowski KA, Masters KS. 2009. In vitro adipogenic
differentiation of preadipocytes varies with differentiation stimulus, culture
dimensionality, and scaffold composition. Tissue Engineering Part A 15:3389–3399
DOI 10.1089/ten.TEA.2008.0293.
Stern JH, Rutkowski JM, Scherer PE. 2016. Adiponectin, leptin, and fatty acids in
the maintenance of metabolic homeostasis through adipose tissue crosstalk. Cell
Metabolism 23(5):770–784 DOI 10.1016/j.cmet.2016.04.011.
Tang QQ, Otto TC, LaneMD. 2003.Mitotic clonal expansion: a synchronous process
required for adipogenesis. Proceedings of the National Academy of Sciences of the
United States of America 100:44–49 DOI 10.1073/pnas.0137044100.
Tomas E, Tsao T-S, Saha AK, Murrey HE, Cheng Zhang C, Itani SI, Lodish HF,
Ruderman NB. 2002. Enhanced muscle fat oxidation and glucose transport by
Christian et al. (2018), PeerJ, DOI 10.7717/peerj.4641 15/16
ACRP30 globular domain: Acetyl–CoA carboxylase inhibition and AMP-activated
protein kinase activation. Proceedings of the National Academy of Sciences of the
United States of America 99:16309–16313 DOI 10.1073/pnas.222657499.
VonHeimburg D, KuberkaM, Rendchen R, Hemmrich K, Rau G, Pallua N. 2003.
Preadipocyte-loaded collagen scaffolds with enlarged pore size for improved
soft tissue engineering. International Journal of Artificial Organs 26:1064–1076
DOI 10.1177/039139880302601204.
Wrann CD, Rosen ED. 2012. New insights into adipocyte-specific leptin gene expression.
Adipocyte 1:168–172 DOI 10.4161/adip.20574.
Xu A,Wang Y, KeshawH, Xu LY, LamKSL, Cooper GJS. 2003. The fat-derived
hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in
mice. Journal of Clinical Investigation 112:91–100 DOI 10.1172/JCI200317797.
Yamauchi T, Kamon J, Minokoshi Y, Ito Y,Waki H, Uchida S, Yamashita S, Noda
M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D,
Kimura S, Nagai R, Kahn BB, Kadowaki T. 2002. Adiponectin stimulates glucose
utilization and fatty-acid oxidation by activating AMP-activated protein kinase.
Nature Medicine 8:1288–1295 DOI 10.1038/nm788.
Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T,
Murakami K, Tsuboyama-Kasaoka N. 2001. The fat-derived hormone adiponectin
reverses insulin resistance associated with both lipoatrophy and obesity. Nature
Medicine 7:941–946 DOI 10.1038/90984.
ZengW, Pirzgalska RM, Pereira MMA, Kubasova N, Barateiro A, Seixas E, Lu Y-H,
Kozlova A, Voss H, Martins GG. 2015. Sympathetic neuro-adipose connections
mediate leptin-driven lipolysis. Cell 163:84–94 DOI 10.1016/j.cell.2015.08.055.
Christian et al. (2018), PeerJ, DOI 10.7717/peerj.4641 16/16
